RPR Sons Advisors Private Limited, P.Suneela Rani jointly holding Revised's most recent trade in Aurobindo Pharma Ltd. was a Pledge of 3,016,000 Equity Shares done at an average price of Rs. 828.9 . Disclosure was reported to the exchange on Dec. 21, 2020 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for RPR Sons Advisors Private Limited, P.Suneela Rani jointly holding Revised in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (jointly holding) (Re-revised) | Promoter Group | Pledge | 21 Dec 2020 | 3,016,000 | 196,376,250 (33.51%) | 0.51% | 828.9 | 2,500,000,000 | 12 Oct 2020 12 Oct 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |
| Aurobindo Pharma | RPR Sons Advisors Private Limited, P.Suneela Rani (jointly holding) (Revised) | Promoter Group | Revoke | 21 Dec 2020 | 3,016,000 | 196,376,250 (33.51%) | 0.51% | 828.9 | 2,500,000,000 | 12 Oct 2020 12 Oct 2020 |
Insider Trading | Equity Shares | Creation Of Pledge |